KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to -$39.0 million.

  • Hims & Hers Health's Cash from Financing Activities fell 48.69% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.5 million, marking a year-over-year increase of 92877.26%. This contributed to the annual value of -$107.8 million for FY2024, which is 83982.57% down from last year.
  • Per Hims & Hers Health's latest filing, its Cash from Financing Activities stood at -$39.0 million for Q3 2025, which was down 48.69% from $889.2 million recorded in Q2 2025.
  • Hims & Hers Health's 5-year Cash from Financing Activities high stood at $889.2 million for Q2 2025, and its period low was -$39.0 million during Q3 2025.
  • Over the past 5 years, Hims & Hers Health's median Cash from Financing Activities value was -$4.0 million (recorded in 2023), while the average stood at $47.9 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 1330897.44% in 2022, then soared by 364745.26% in 2025.
  • Quarter analysis of 5 years shows Hims & Hers Health's Cash from Financing Activities stood at -$78000.0 in 2021, then tumbled by 13308.97% to -$10.5 million in 2022, then skyrocketed by 62.11% to -$4.0 million in 2023, then crashed by 244.49% to -$13.7 million in 2024, then plummeted by 185.74% to -$39.0 million in 2025.
  • Its Cash from Financing Activities was -$39.0 million in Q3 2025, compared to $889.2 million in Q2 2025 and -$23.0 million in Q1 2025.